158 related articles for article (PubMed ID: 15838301)
21. Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes.
Antonelli A; Ferrari SM; Frascerra S; Ruffilli I; Gelmini S; Minuto M; Pupilli C; Miccoli P; Sellari-Franceschini S; Ferrannini E; Fallahi P
Mol Cell Endocrinol; 2012 Feb; 349(2):255-61. PubMed ID: 22101320
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
23. [An exploratory study on mechanism of PPARalpha activators-induced plasminogen activator inhibitor-1 expression in HepG-2 cells].
Ye P; He YL; Wang Q; Liu YX
Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):743-6. PubMed ID: 15631825
[TBL] [Abstract][Full Text] [Related]
24. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
25. Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.
Soria A; González Mdel C; Vidal H; Herrera E; Bocos C
Mol Cell Biochem; 2005 May; 273(1-2):97-107. PubMed ID: 16013444
[TBL] [Abstract][Full Text] [Related]
26. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Ye P; Fang H; Zhou X; He YL; Liu YX
Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
[TBL] [Abstract][Full Text] [Related]
27. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
[TBL] [Abstract][Full Text] [Related]
28. L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1-phosphate generation.
Chao HH; Chen CH; Liu JC; Lin JW; Wong KL; Cheng TH
J Nutr Biochem; 2010 Jul; 21(7):580-8. PubMed ID: 19447019
[TBL] [Abstract][Full Text] [Related]
29. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
Cao W; Li F; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
[TBL] [Abstract][Full Text] [Related]
30. Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.
Becker J; Delayre-Orthez C; Frossard N; Pons F
Pulm Pharmacol Ther; 2008; 21(2):324-30. PubMed ID: 17897854
[TBL] [Abstract][Full Text] [Related]
31. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
32. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
33. The peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.
Kuno T; Hata K; Takamatsu M; Hara A; Hirose Y; Takahashi S; Imaida K; Tanaka T
Int J Mol Sci; 2014 May; 15(5):9160-72. PubMed ID: 24857924
[TBL] [Abstract][Full Text] [Related]
34. Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways.
Asavapanumas N; Kittayaruksakul S; Meetam P; Muanprasat C; Chatsudthipong V; Soodvilai S
Drug Metab Pharmacokinet; 2012; 27(5):513-9. PubMed ID: 22473497
[TBL] [Abstract][Full Text] [Related]
35. Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy.
Li R; Zheng W; Pi R; Gao J; Zhang H; Wang P; Le K; Liu P
FEBS Lett; 2007 Jul; 581(17):3311-6. PubMed ID: 17597616
[TBL] [Abstract][Full Text] [Related]
36. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.
Glenn DJ; Rahmutula D; Nishimoto M; Liang F; Gardner DG
Cardiovasc Res; 2009 Nov; 84(2):209-17. PubMed ID: 19546173
[TBL] [Abstract][Full Text] [Related]
37. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
[TBL] [Abstract][Full Text] [Related]
38. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
Zuo N; Zheng X; Liu H; Ma X
Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
[TBL] [Abstract][Full Text] [Related]
39. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D
J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
